Latest Breaking News On - Dermatology registrar - Page 1 : comparemela.com

LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing current understanding of the skin microbiome in healthy and diseased skin - using their novel testing kits. Atopic dermatitis (AD) is a multifactorial chronic and recurrent inflammatory skin disease, affecting 20% of children and 10% of adults. Roughly 29% are moderate to severe cases, with healthcare and socio-economic costs of Pound 723M per year. This US $500k (equivalent to Pound 400k) project will be funded over 18 months to further the understanding of genetic and skin microbiome inputs, during disease progression, that may lead to helping to identify and stratify patients in the future. "We see a future where patients with recurrent and debilitating skin conditions are diagnosed in a highly precise way, at the point of care, which can then be followed by effective and targeted treatme

United kingdomCity ofBen holmesNatalya foxOliver worsleySequential skin ltdInnovate united kingdomDermatology registrarAlbert dashiScrum venturesLondon and new york singaporeJune 29022 prnewswire sequential skin ltdA leading skin genomics start upAs been awarded an innovate uk smart grant to funda project on advancing current understanding of the skin microbiome in healthy and diseased using their novel testing kits atopic dermatitis ad isa multifactorial chronic recurrent inflammatory diseaseFfecting 20 of children and 10 adults roughly 29 are moderate to severe cases